103 related articles for article (PubMed ID: 18718648)
1. Risk factors for a serous cancer precursor ("p53 signature") in women with inherited BRCA mutations.
Saleemuddin A; Folkins AK; Garrett L; Garber J; Muto MG; Crum CP; Tworoger S
Gynecol Oncol; 2008 Nov; 111(2):226-32. PubMed ID: 18718648
[TBL] [Abstract][Full Text] [Related]
2. Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations.
Conner JR; Meserve E; Pizer E; Garber J; Roh M; Urban N; Drescher C; Quade BJ; Muto M; Howitt BE; Pearlman MD; Berkowitz RS; Horowitz N; Crum CP; Feltmate C
Gynecol Oncol; 2014 Feb; 132(2):280-6. PubMed ID: 24333842
[TBL] [Abstract][Full Text] [Related]
3. The ovary is an alternative site of origin for high-grade serous ovarian cancer in mice.
Kim J; Coffey DM; Ma L; Matzuk MM
Endocrinology; 2015 Jun; 156(6):1975-81. PubMed ID: 25815421
[TBL] [Abstract][Full Text] [Related]
4. Neoplastic cellularity is associated with clinical and molecular features of high-grade serous ovarian carcinoma.
Morse CB; Norquist BM; Harrell MI; Agnew KJ; Gray HJ; Urban RR; Garcia RL; Goff BA; Swisher EM
Gynecol Oncol; 2016 Nov; 143(2):389-392. PubMed ID: 27575909
[TBL] [Abstract][Full Text] [Related]
5. Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.
Gruessner C; Gruessner A; Glaser K; AbuShahin N; Zhou Y; Laughren C; Wright H; Pinkerton S; Yi X; Stoffer J; Azodi M; Zheng W; Chambers SK
Cancer Prev Res (Phila); 2014 Sep; 7(9):896-905. PubMed ID: 24950779
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes following identification of an incidental p53 signature in the fallopian tube.
MacARTHUR EC; Radolec M; Rinda Soong T; Elishaev E; Buckanovich R; Taylor SE; Lesnock J
Gynecol Oncol Rep; 2024 Apr; 52():101359. PubMed ID: 38495800
[TBL] [Abstract][Full Text] [Related]
7. Ovarian Cancer: From Precursor Lesion Identification to Population-Based Prevention Programs.
Sowamber R; Lukey A; Huntsman D; Hanley G
Curr Oncol; 2023 Nov; 30(12):10179-10194. PubMed ID: 38132375
[TBL] [Abstract][Full Text] [Related]
8. Effect of exercise on peritoneal microenvironment and progression of ovarian cancer.
Morrisson MJ; Bi F; Yang K; Cady SL; Hartwich TM; Cerchia AP; Li Z; Kim J; Irwin ML; Yang-Hartwich Y
Am J Cancer Res; 2021; 11(10):5045-5062. PubMed ID: 34765311
[TBL] [Abstract][Full Text] [Related]
9. A Review of Principal Studies on the Development and Treatment of Epithelial Ovarian Cancer in the Laying Hen
Pal P; Starkweather KN; Hales KH; Hales DB
Comp Med; 2021 Aug; 71(4):271-284. PubMed ID: 34325771
[TBL] [Abstract][Full Text] [Related]
10. Histone Modifying Enzymes in Gynaecological Cancers.
Ramarao-Milne P; Kondrashova O; Barry S; Hooper JD; Lee JS; Waddell N
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33669182
[TBL] [Abstract][Full Text] [Related]
11. Ovarian BDNF promotes survival, migration, and attachment of tumor precursors originated from p53 mutant fallopian tube epithelial cells.
Kang M; Chong KY; Hartwich TMP; Bi F; Witham AK; Patrick D; Morrisson MJ; Cady SL; Cerchia AP; Kelk D; Liu Y; Nucci J; Madarikan O; Ueno D; Shuch BM; Yang-Hartwich Y
Oncogenesis; 2020 May; 9(5):55. PubMed ID: 32471985
[TBL] [Abstract][Full Text] [Related]
12. Performance of the pattern-based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinoma.
Kortekaas KE; Solleveld-Westerink N; Tessier-Cloutier B; Rutten TA; Poelgeest MIE; Gilks CB; Hoang LN; Bosse T
Histopathology; 2020 Jul; 77(1):92-99. PubMed ID: 32236967
[TBL] [Abstract][Full Text] [Related]
13. Relationship between the precursors of high grade serous ovarian cancer and patient characteristics: decreased incidence of the p53 signature in pregnant women.
Ida T; Fujiwara H; Kiriu T; Taniguchi Y; Kohyama A
J Gynecol Oncol; 2019 Nov; 30(6):e96. PubMed ID: 31576690
[TBL] [Abstract][Full Text] [Related]
14. Ovarian Cancer Previvors: How to manage these patients?
Carvalho JP; Baracat EC; Carvalho FM
Clinics (Sao Paulo); 2019; 74():e1343. PubMed ID: 31340254
[No Abstract] [Full Text] [Related]
15. Back to the Future? The Fallopian Tube, Precursor Escape and a Dualistic Model of High-Grade Serous Carcinogenesis.
Soong TR; Kolin DL; Teschan NJ; Crum CP
Cancers (Basel); 2018 Nov; 10(12):. PubMed ID: 30486509
[TBL] [Abstract][Full Text] [Related]
16. p53 in AgRP neurons is required for protection against diet-induced obesity via JNK1.
Quiñones M; Al-Massadi O; Folgueira C; Bremser S; Gallego R; Torres-Leal L; Haddad-Tóvolli R; García-Caceres C; Hernandez-Bautista R; Lam BYH; Beiroa D; Sanchez-Rebordelo E; Senra A; Malagon JA; Valerio P; Fondevila MF; Fernø J; Malagon MM; Contreras R; Pfluger P; Brüning JC; Yeo G; Tschöp M; Diéguez C; López M; Claret M; Kloppenburg P; Sabio G; Nogueiras R
Nat Commun; 2018 Aug; 9(1):3432. PubMed ID: 30143607
[TBL] [Abstract][Full Text] [Related]
17. Modulation of p53 during bacterial infections.
Siegl C; Rudel T
Nat Rev Microbiol; 2015 Dec; 13(12):741-8. PubMed ID: 26548915
[TBL] [Abstract][Full Text] [Related]
18. Stathmin 1 and p16(INK4A) are sensitive adjunct biomarkers for serous tubal intraepithelial carcinoma.
Novak M; Lester J; Karst AM; Parkash V; Hirsch MS; Crum CP; Karlan BY; Drapkin R
Gynecol Oncol; 2015 Oct; 139(1):104-11. PubMed ID: 26206555
[TBL] [Abstract][Full Text] [Related]
19. Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma.
Tolcher MC; Swisher EM; Medeiros F; Lima JF; Hilderbrand JL; Donovan JL; Garcia RL; Cliby WA; Dowdy SC
Int J Gynecol Pathol; 2015 Jan; 34(1):57-64. PubMed ID: 25473754
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia infection depends on a functional MDM2-p53 axis.
González E; Rother M; Kerr MC; Al-Zeer MA; Abu-Lubad M; Kessler M; Brinkmann V; Loewer A; Meyer TF
Nat Commun; 2014 Nov; 5():5201. PubMed ID: 25392082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
